Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.99+0.01 (+0.03%)
At close: 04:00PM EDT
38.99 0.00 (0.00%)
After hours: 07:52PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close38.98
Open38.92
Bid38.95 x 1400
Ask38.99 x 1100
Day's Range38.62 - 39.13
52 Week Range36.57 - 55.00
Volume5,611,833
Avg. Volume6,566,437
Market Cap33.697B
Beta (5Y Monthly)0.59
PE Ratio (TTM)6.61
EPS (TTM)5.90
Earnings DateOct 12, 2022 - Oct 17, 2022
Forward Dividend & Yield1.92 (4.92%)
Ex-Dividend DateAug 18, 2022
1y Target Est41.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-17% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for WBA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Walgreens Boots Alliance, Inc.
    Analyst Report: Walgreens Boots Alliance IncWalgreens Boots Alliance Inc. based in Deerfield, Illinois, is a holding company created in December 2014 when Walgreen completed its purchase of privately held Alliance Boots. The company generated $133 billion in FY21 sales from continuing operations. After divesting its healthcare distribution business WBA has presence in more than 9 countries. About 85% of revenue is from the United States. The company has over 14,000 stores under the Walgreen, Duane Reade and Boots names. WBA owns about 25% of AmerisourceBergen. WBA's fiscal year ends on August 31. The company has reclassified its operations with the divestiture of the wholesale businesses and the pharmacy businesses in Norway, Lithuania, and the Netherlands. The new organization has a United States unit, an International unit, a Corporate & Other segment, which includes corporate costs and company investments, and WBA will be adding a new Walgreens Health segment to include recent investments in VillageMD, CareCentrix and Shields Health Solutions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • Motley Fool

    1 Absurdly Cheap High-Yield Dividend Stock I Just Bought

    Walgreens Boots Alliance (NASDAQ: WBA) stock is a steady performer with a very enticing dividend yield. In this video clip from "The Rank" on Motley Fool Live, recorded on July 27, Fool.com contributors Matt Frankel and Jason Hall examine several factors that make it quite appealing for investment. Matt Frankel: What shocked me when I did a little research for the show is Walgreens has a 5% dividend yield right now.

  • Motley Fool

    2 Trends That Suggest Healthcare Stocks Can Beat the Bear Market

    Healthcare is generally a safe place to invest. Year to date, the Health Care Select Sector SPDR Fund has only fallen 7% while the S&P 500 has declined by 14%. A couple of promising trends suggest this pattern could continue for the foreseeable future.

  • Reuters

    Tennessee sues Walgreens pharmacy chain over opioid distribution

    The state of Tennessee sued Walgreens on Wednesday, accusing the retail pharmacy giant of fueling the state's opioid epidemic by willfully flooding the market with an oversupply of prescription narcotics in violation of consumer protection and public nuisance laws. According to the lawsuit, Walgreens used its position as one of the state's largest pharmacy chains to dispense over 1.1 billion oxycodone and hydrocodone pills within Tennessee from 2006 to 2020, roughly equivalent to 175 tablets for every resident of the state. "The sheer volume of opioids that Walgreens released into Tennessee was unreasonable and highly suspicious on its face," said the 148-page lawsuit, filed in Knox County Circuit Court.

Advertisement
Advertisement